| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |